Last year wasn't all that great for Mylan N.V. (NASDAQ: MYL). However, the drugmaker began to see some signs of improvement when it reported its fourth-quarter resultsat the end of February. And Mylan's outlook pointed to a better year in 2018.
Mylan's 1st Quarter Results Are Weaker Than They Might Seem
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться